Dynavax Enters Into Supply and Option Agreement for Development of Universal Influenza Vaccine

News   Jul 24, 2008

 
Dynavax Enters Into Supply and Option Agreement for Development of Universal Influenza Vaccine
 
 
 

RELATED ARTICLES

PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug Discovery

News

Investment to fund expansion of operations and progression of drug target pipeline.

READ MORE

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.

READ MORE

Molecule Prevents Common Cold Virus from Hijacking Human Cells

News

Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE